Synthesis and expression of mRNA encoding for different versican splice variants is related to the aggregation of human epithelial mesothelioma cells

Anticancer Research

Volumn 22, Issue 6 C, 2002, Pages 4157-4162

  Syrokou, Alexandra ^a   Dobra, Katalin ^b   Tzanakakis, George N ^c   Hjerpe, Anders ^b   Karamanos, Nikos K ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c NONE

Author keywords

Cell aggregation; Glycosaminoglycan; Malignant mesothelioma; Perlecan; Proteoglycans; Versican

Indexed keywords

MESSENGER RNA; PERLECAN; PROTEOGLYCAN; SYNDECAN; VERSICAN;

ARTICLE; CANCER CELL CULTURE; CAPILLARY ELECTROPHORESIS; CELL AGGREGATION; CELL DIFFERENTIATION; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; DISEASE ASSOCIATION; EPITHELIUM CELL; FIBROBLAST; GENE CONTROL; GENETIC CODE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ION EXCHANGE CHROMATOGRAPHY; MESOTHELIOMA; MESOTHELIUM; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; WESTERN BLOTTING;

ALTERNATIVE SPLICING; BLOTTING, WESTERN; CELL AGING; CHROMATOGRAPHY, ION EXCHANGE; EPITHELIAL CELLS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; LECTINS, C-TYPE; MESOTHELIOMA; PROTEIN ISOFORMS; PROTEOCHONDROITIN SULFATES; RNA, MESSENGER; VERSICANS;

EID: 0036875374     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Reddi AH: Extracellular Matrix: Structure and Function. Liss AR Inc, New York, 1984.
2. Kjellen L and Lindahl M: Proteoglycans: structures and interactions. Ann Rev Biochem 60: 443-475, 1991.
3. Elenius K and Jalkanen M: Function of the syndecans - a family of cell surface proteoglycans. J Cell Sci 107: 2975-2982, 1994.
4. Iozzo RV and Murdoch AD: Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and ftinction. FASEB J 10: 598-614, 1996.
5. Doege K, Sakaki M, Horigan E, Hassell JR and Yamada Y: Complete primary structure of the rat cartilage proteoglycan core protein deduced from cDNA clones. J Biol Chem 262: 17757-17767, 1987.
6. Dours-Zimmermann MT and Zimmermann DR: A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J Biol Chem 269: 32992-32998, 1994.
7. Yamagata M, Saga S, Kato M, Bernfield M and Kimata K: Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts. Implications for their roles in cell-substratum adhesion. J Cell Sci 106: 55-65, 1993.
8. Yamagata M and Kimata K: Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican. J Cell Sci 107: 2581-2590, 1994.
9. Zimmermann DR and Ruoslahti E: Multiple domains of the large fibroblast proteoglycan, versican. EMBO J 8: 2975-2981, 1989.
10. Kimata K, Oike Y, Tani K, Shinomura T, Yamagata M, Uritani M and Susuki S: A large chondroitin sulphate proteoglycan (PG-M) synthesized before chondrogenesis in the limb bud of chick embryo. J Biol Chem 261: 13517-13525, 1986.
11. Yamagata M, Shinomura T and Kimata K: Tissue variation of two large chondroitin sulphate proteoglycans (PG-NI/versican and PG-H/aggrecan) in chick embryos. Anat Embryol 187: 433-444, 1993.
12. Yao LY, Moody C, Schonherr E, Wight TN and Sandell LJ: Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry. Matrix Biol 14: 213-225, 1994.
13. Paulus W, Baur I, Dours-Zimmermann MT and Zimmermann DR: Differential expression of versican isoforms in brain tumors. J Neuropathol Exp Neurol 55: 528-33, 1996.
14. Schmalfeldt M, Dours-Zimmermann MT, Winterhalter KH and Zimmermann DR: Versican V2 is a major extracellular matrix component of the mature bovine brain. J Biol Chem 273: 15758-64, 1991.
15. Syrokou A, Tzanakakis GN, HJerpe A and Karamanos NK: Proteoglycans in human malignant mesothelioma. Stimulation of their synthesis induced by epidermal, insulin and platelet-derived growth factors involves receptors with tyrosine kinase activity. Biochimie 81: 733-744, 1999.
16. Noonan DM and Hassel JR: Proteoglycans of basement membranes. In: Rohrbach D.H., Timpl R., editors: Molecular and Cellular Aspects of Basement Membranes. New York: Academic Press p 189-210, 1993.
17. Murdoch AD, Dodge GR, Cohen I, Tuan RS and Iozzo RV: Primary structure of the human heparan sulphate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J Biol Chem 267: 8544-57, 1992.
18. Iozzo RV: Matrix proteoglycans: from molecular design to cellular function. Ann Rev Biochem 67: 609-652, 1998.
19. Craighead JE and Kane EB: The pathogenesis of malignant and non malignant serosal C-lesions in body cavities consequent to asbestos exposure. In: Jaurand M-C, Bignon J, editors: The Mesothelial Cell and Mesothelioma. New York: Mercel Dekker Inc, p. 242249,1994.
20. Tzanakakis GN, Karamanos NK, Klominek J and Hjerpe A: Glycosaminoglycans from two human malignant mesothelioma cell lines: determination, distribution, and effect of platelet-derived growth factor on their synthesis. Biochem Cell Biol 73: 59-66, 1995.
21. Tzanakakis GN, Hjerpe A, Karamanos NK: Proteoglycan synthesis induced by transforming and basic fibroblast growth factors in human malignant mesothelioma is mediated through specific receptors and the tyrosine kinase intracellular pathway. Biochimie 79: 323-332, 1997.
22. Tzanakakis GN, Karamanos NK and Hjerpe A: Effects on glycosaminoglycan synthesis in cultured human mesothelioma cells of transforming, epidermal, and fibroblast growth factors and their combinations with platelet-derived growth factor. Exp Cell Res 220: 130-137, 1995.
23. Syrokou A, Tzanakakis GN, Tsegenidis T, Hjerpe A and Karamanos NK: Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure - function relationship. Cell Prolif 32: 85-99, 1999.
24. Collins CL, Ordoner NG, Schaefer R, Cook CD, Xie S-S, Granger J, Hsu P-L, Fink L and Hsu S-M: Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma. Am J Pathol 141: 827-833, 1992.
25. Dobra K, Anding M, Syrokou A, Karamanos NK and Hjerpe A: Differentiation of mesothelioma cells is influenced by the expression of proteoglycans. Exp Cell Res 258: 12-22, 2000.
26. Perides G, Rahemtulla F, Lane WS, Asher RA and Bigani A: Isolation of a large aggregating proteoglycan from human brain. J Biol Chem 267: 23883-23887, 1992.
27. Karamanos NK: Proteoglycans: Biological roles and strategies for isolation and T determination of their glycan constituents. In: Kamp RM, Kyriakidis DA, Choli-Papadopoulou T, editors: Proteome and Protein Analysis, Berlin: Springer-Verlag p. 342-363, 1998.
28. Karamanos NK, Syrokou A, Vanky P, Nurminen M and Hjerpe A: Determination of twenty-four variously sulphated galactosaminoglycan- and hyaluronan-derived disaccharides by high-performance liquid chromatography. Anal Biochem 221: 189-199, 1994.
29. Karamanos NK, Axelson S, Vanky P, Tzanakakis GN and Hjerpe A: Determination of hyaluronan and galactosaminoglycan disaccharides by high-performance capillary electrophoresis at the attomole level. Application to analyses of tissue and cell culture proteoglycans. J Chromatogr A 696: 295-305, 1995.
30. Hashimoto N, Morikava K, Kikuchi M, Yoshida K and Tokuyasu K: Purification and properties of a new keratan sulphate degrading enzyme. Seikagaku 60: 935-938, 1998.
31. Karamanos NK, Vanky P, Tzanakakis GN and Hjerpe A: High-performance capillary electrophoresis to characterise heparin and heparan sulphate disaccharides. Electrophoresis 17: 391-395, 1996.
32. Karamanos NK, Vanky P, Tzanakakis GN, Tsegenidis T and Hjerpe A: Ion - pair highperformance liquid chromatography for determining disaccharide composition in heparin and heparan sulphate. J Chromatogr A 765: 165-179, 1997.
33. van Det NF, van den Born J, Tasma JT, Verhagen NAM, ven den Heuvel LPWJ, Berden JHM, Bruijin JA, Daha MR and van der Woude FJ: Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro. Biochem J 307: 759-768, 1995.
34. Kahari VM, Larjava H and Uitto J: Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta I up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA level in human fibroblasts in culture. J Biol Chem 266: 10608-10615, 1991.
35. Ohiwa N, Fukata S, Fukatsu T, Nagasaka T, Nara Y, Lai S, Nakashima N and Takeuchi J: Immunohistochemical localization of proteoglycans in non-epithelial tumor tissues. Connect Tissue 22: 11-19, 1991.
36. Nara Y, Kato Y, TorJi Y, Tsuji Y, Nakagaki S, Goto S, Isobe H, Nakashima N and Takenchi J: Immunohistochemical loclization of extracellular matrix components in human breast tumors with special reference to PG-M/versican. Histochem J 29: 21-30, 1997.
37. Kataoka H, Wikstr6m B, Klominek J, Gay RE, Gay S and Hjerpe A: Immunocytochemical demonstration of collagen types I and IV in cells isolated from malignant mesothelioma and in lung cancer cell lines. Lung Cancer 6: 16-27, 1990.
38. Iozzo RV: Perlecan: a gem of a proteoglycan. Matrix Biol 14: 203-208, 1994.
39. Aviezer D, Hecht D, Safran M, Eisinger M, David G and Yanon A: Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis and anglogenesis. Cell 79: 1005-1013, 1994.
40. Hayashi K, Madri JA and Yurchenco PD: Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan. J Cell Biol 119: 945-959, 1992.